Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats

Metabolic syndrome (MetS) is a combination of metabolic disorders that can predispose individuals to benign prostatic hyperplasia (BPH). The inhibition of the cannabinoid 1 (CB1) receptor has been used to treat metabolic disorders in animal models. This study reports the use of a peripherally restri...

Descripción completa

Detalles Bibliográficos
Autores principales: Eid, Basma G, Neamatallah, Thikryat, Binmahfouz, Lenah S, Bagher, Amina M, Alamoudi, Abdulmohsin J, Aldawsari, Hibah Mubarak, Hanafy, Abeer, Hasan, Atif, El-Bassossy, Hany M, Abdel-Naim, Ashraf B, Vemuri, Kiran, Makriyannis, Alexandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655885/
https://www.ncbi.nlm.nih.gov/pubmed/37212036
http://dx.doi.org/10.17305/bb.2023.9173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655885/
https://www.ncbi.nlm.nih.gov/pubmed/37212036
http://dx.doi.org/10.17305/bb.2023.9173

Ejemplares similares